The identification of proteomic biomarkers typically involves high-throughput technologies like mass spectrometry and protein microarrays. These techniques allow for the comprehensive analysis of the proteome, the entire set of proteins expressed by an organism. The identified proteins are then validated through clinical studies to ensure their relevance and reliability.
